NCT02050594View on ClinicalTrials.gov

Ipilimumab 12-month Intensive Pharmacovigilance Protocol

CompletedOBSERVATIONAL
Enrollment

6

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

February 28, 2015

Study Completion Date

February 28, 2015

Conditions
Melanoma
Interventions
DRUG

Ipilimumab

Trial Locations (1)

Unknown

Local Institution, Caracas

Sponsors

Collaborators (1)

JSS Medical Research Inc.
All Listed Sponsors
collaborator

JSS Medical Research Inc.

INDUSTRY

lead

Bristol-Myers Squibb

INDUSTRY

NCT02050594 - Ipilimumab 12-month Intensive Pharmacovigilance Protocol | Biotech Hunter | Biotech Hunter